Ask the experts II

23.09.2024

EU HTA market access strategy panel

Remote, 23.09.2024

Strategically digested information

Do you need help or advice in understanding the new EU HTA framework? Do you have questions regarding the arising chances and risks for your business? Are you looking to expand your network and get in touch with strategic market access professionals?

Join our EU HTA expert discussions

Our panel of industry and market access professionals has the answers for you!

Get in touch

Ihr Ansprechpartner Dr. rer. nat. Ingo Hantke

Dr. rer. nat. Ingo Hantke
Director Market Access
M.Sc. Life Science

Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

E-Mail

Event

Ask the experts III

10th of Dec 2024

Dr. rer. nat. Ingo Hantke

EU HTA market access strategy panel

Blog

SKC joins the MAP group, thereby broadening further the group’s European platform

Publication

Clinical Endpoint Results & LLMs

ISPOR Europe 2024: Poster presentation

Blog

Combination discount - a bureaucratic monster

Implementation regulation of the combination discount according to section 130e SGB V named by the BMG

Whitepaper

One HTA to assess them all 2.0 - The strategic perspective on EU HTA updated

EU HTA: European Health Technology Assessment (JCA)

Achieve planning security: With us you can align your projects and your resource planning comprehensively and at an early stage on EU HTA and its implications for market access.

to the top